Yttrium-90 Anti-CD25-BEAM-Conditioning for Autologous Hematopoietic Cell Transplantation in Peripheral T Cell Lymphoma.

Interferons in the treatment of myeloproliferative neoplasms.

Phase 2 study of add-on parsaclisib in myelofibrosis patients with suboptimal response to ruxolitinib: Final results.

Reappraisal of mast cell leukemia based on a single institution review of 16 cases: Mast cell morphology determines clinical outcome.

Mast cell cytomorphology and treatment outcome in mast cell leukemia.

Genetic features and outcomes of allogeneic transplant in patients with WT1-mutated myeloid neoplasms.

Patient-reported Outcomes and Quality of Life in Anemic and Symptomatic Patients With Myelofibrosis: Results From the MOMENTUM Study.

More than just risk for Alzheimer's disease: APOE ε4's impact on the aging brain.

Germline Variants in Childhood Cutaneous Melanoma.

PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in Patients with Myelofibrosis.